SCHEMBL19088738

SCHEMBL19088738

Cc1ccc(N(C)N)c(N)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.52
ALOX15 P16050 2/20 0.52
CYP3A4 P08684 2/20 0.52
TP53 P04637 1/20 0.52
THRB P10828 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
ALDH1A1 P00352 3/20 0.50
HSD17B10 Q99714 1/20 0.46
CA1 P00915 1/20 0.45
GAA P10253 2/20 0.41
KMT2A Q03164 1/20 0.41
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
SLC6A4 P31645 5/20 0.37
SLC6A2 P23975 2/20 0.37
SLC6A3 Q01959 2/20 0.37
TSHR P16473 1/20 0.35
HTR5A P47898 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2409781 0.84 GAA (0.57) TDP1ALOX15CYP3A4TP53THRB
SCHEMBL21416996 0.82 TDP1 (0.52) TDP1ALOX15CYP3A4TP53THRB
SCHEMBL19088749 0.82 TDP1 (0.52) TDP1ALOX15CYP3A4TP53THRB
SCHEMBL4804383 0.79 ALDH1A1 (0.41) TDP1ALOX15CYP3A4TP53THRB
SCHEMBL19848188 0.77 TDP1 (0.46) TDP1ALOX15CYP3A4TP53THRB
SCHEMBL20888625 0.77 TDP1 (0.46) TDP1ALOX15CYP3A4TP53THRB
SCHEMBL24651364 0.76 GAA (0.70) TDP1ALOX15CYP3A4TP53SMN1; SMN2
SCHEMBL20888893 0.76 GAA (0.39) ALOX15ALDH1A1GAAKMT2AMAPT
SCHEMBL2411170 0.74 TDP1 (0.48) TDP1ALOX15CYP3A4TP53THRB
SCHEMBL19848535 0.74 TDP1 (0.43) TDP1ALOX15CYP3A4TP53THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3633380-A1 METHOD FOR PREDICTING THERAPEUTIC EFFECT OF LSD1 INHIBITOR BASED ON EXPRESSION OF INSM1 Taiho Pharmaceutical Co., Ltd. (JP) 2020-04-08 EP disclosed
EP-3467930-A1 NONAQUEOUS ELECTROLYTE AND NONAQUEOUS SECONDARY BATTERY ASAHI KASEI KABUSHIKI KAISHA (JP) 2019-04-10 EP disclosed
WO-2017114377-A1 BENZYL HETEROCYCLIC COMPOUND DERIVATIVE AND PHARMACEUTICAL APPLICATION THEREOF 四川海思科制药有限公司 2017-07-06 WO disclosed